ARTICLE

FindCenter AddIcon

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

By Maureen Meehan — 2017

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

Read on hightimes.com

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

Article
Sophie Putka
2021
FindCenter AddIcon
FindCenter Post-Image

Two Men Share Their Experience with Treatment for PTSD

This is a story about two very different men, their fight with post-traumatic stress disorder, and their coping options.

Article
Lewis Turner
2021
FindCenter AddIcon

EXPLORE TOPIC

MDMA